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Abstract
Aims/hypothesis. Skeletal muscle of pre-diabetic pa-
tients is characterised by a diminished capacity to 
handle fatty acids. A diminished content of several en-
zymes involved in fatty-acid transport and oxidation
have been suggested to underlie these defects. The
aim of this study was to investigate whether the com-
bination of dietary advice, increased physical activity
and weight loss improves lipid metabolic gene and
protein expression in skeletal muscle of subjects with
impaired glucose tolerance.
Methods. Before and after 1 year of a lifestyle-inter-
vention programme, expression of several genes and
proteins involved in lipid metabolism were measured
in vastus lateralis muscle biopsies from subjects in the
intervention (n=7) and control group (n=6).
Results. After 1 year the intervention group had an im-
proved glycaemic control and reduced body fat com-
pared to the control group. Significant differences
were observed for acetyl CoA-carboxylase 2 and un-
coupling protein 2 expression (ACC2: −16.8±12.4%
vs +51.5±32.3% for the intervention and control
group respectively; p<0.05) (UCP2: −26.9±10.3% vs
+10.5±6.2% for the intervention and control group re-
spectively; p<0.05). Change in 3-hydroxyacyl-CoA
dehydrogenase protein content tended to be different
between groups (+3.2±1.1 vs −0.9±1.9 U/mg.ww for
the intervention and control group, p=0.07).
Conclusions/interpretation. Lifestyle changes leading
to an improved glycaemic control and reduced adipos-
ity, resulted in a down-regulation of ACC-2 and UCP2
expression and in an increase in HAD protein content,
reflecting a better capacity to utilise fatty acids. [Dia-
betologia (2003) 46:1082–1089]
Keywords Impaired glucose tolerance, acetyl CoA
carboxylase, muscle biopsy, lipid metabolism, uncou-
pling protein, lifestyle-intervention, fatty acids, fat ox-
idation, insulin resistance.
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Skeletal muscle has an important role in the overall
utilisation and oxidation of fatty acids because of its
large mass and because lipids are the principal oxida-
tive substrate after an overnight fast and during mod-
erate exercise. Type 2 diabetes mellitus is character-
ised by abnormalities in skeletal muscle glucose and
lipid metabolism [1]. Uptake and oxidation of NEFA
are diminished under postabsorptive conditions in
Type 2 diabetes [2, 3] and IGT [4], whereas during
postprandial conditions there is impaired suppression
of muscle NEFA uptake in Type 2 diabetes [2], fa-
vouring increased storage of lipids. Indeed, the diabet-
ic muscle is characterised by increased levels of triac-
ylglycerols (intramuscular triacylglycerols, IMTG) [5,
6], which is strongly associated with the degree of in-
sulin resistance, even in non-diabetic subjects [7, 8].
Thus, alterations in fatty-acid metabolism can play an
important role in the development of insulin resistance
and Type 2 diabetes mellitus [1, 9].
Several mechanisms have been suggested to under-
lie the diminished capacity of the pre-diabetic muscle
to oxidise fatty acids. Several studies have shown that
the insulin-resistant skeletal muscle is characterised
by a diminished content of proteins or enzymes in-
volved in fatty-acid transport (cytosolic fatty acid
binding protein, FABPc), ß-oxidation (3-hydroxy fat-
ty-acyl CoA dehydrogenase, HAD) and the Krebs 
cycle (citrate synthase, CS) [3, 10]. The metabolic ca-
pacity of the insulin-resistant skeletal muscle seems to
be organised towards fat esterification rather than oxi-
dation [10]. Reduced activity of the rate-limiting step
in fatty acid oxidation, carnitine-palmitoyl transferase
1 (CPT-1), either to decreased expression or more pro-
nounced inhibition by malonyl-CoA, has been sug-
gested to explain the diminished ability to oxidise fat-
ty acids [11]. Finally, a role is suggested for uncou-
pling proteins (UCP) in the disturbed handling of fatty
acids in Type 2 diabetes [12, 13].
Weight reduction is known to improve insulin sen-
sitivity and reduce the degree of glucose intolerance.
However substantial (dietary-induced) weight reduc-
tion did not improve the disturbed plasma-derived fat-
ty acid oxidation in Type 2 diabetic subjects [14]. 
Neither did weight reduction correct the metabolic de-
rangement’s of skeletal muscle partitioning fat to-
wards esterification rather than oxidation, in obese
non-diabetic subjects [10]. In contrast, physical exer-
cise is a potent enhancer of insulin sensitivity and also
increases the capacity of the skeletal muscle to oxidise
fatty acids. The enhanced fat oxidation after exercise
training is associated with upregulation of genes in-
volved in fatty-acid uptake such as membrane-associ-
ated fatty-acid binding protein (FABPpm) and fatty-
acid translocase (FAT/CD36) [15, 16], and genes in-
volved in fatty-acid oxidation, as CPT-1, acetyl-CoA
carboxylase (ACC) and HAD [16, 17, 18]. Therefore,
combining exercise, dietary advice and weight-loss
could be an effective strategy because this would have
the potential to compensate for the impaired capacity
to oxidise fatty acids and stimulate expression of
genes involved in lipid metabolism in skeletal muscle
of insulin resistant subjects, in comparison to the lack
of improvement after weight-loss alone. In addition,
the intake of nutrients is another important environ-
mental factor regulating gene expression. Especially
the fatty-acid composition of dietary lipids has a
marked effect on gene expression, and influences fuel
homeostasis in liver and skeletal muscle [19].
We addressed whether the combination of dietary
advice, increased physical activity and moderate
weight loss, a so-called lifestyle-intervention, im-
proves the lipid metabolic mRNA and protein profile
of skeletal muscle in subjects with IGT. Epidemiologi-
cal studies have shown that such a lifestyle interven-
tion program, based on general public health recom-
mendations reduces the progression from IGT to dia-
betes with almost 60% over a 3-year period [20, 21].
Before and after 1 year of a lifestyle-intervention pro-
gram, gene and protein expression related to skeletal
muscle lipid metabolism was measured in biopsies
from the m. vastus lateralis.
Subjects and methods
Subjects and design. The Study on Lifestyle-intervention and
IGT, Maastricht (SLIM) was designed to study whether a diet
and physical activity intervention program can improve glu-
cose tolerance in subjects with a high risk of developing Type
2 diabetes mellitus. A detailed description of the study can be
found elsewhere [22]. In the present study, thirteen subjects
with IGT participating in the larger intervention trial under-
went additional measurements to evaluate the effect of this
lifestyle-intervention program on skeletal-muscle gene expres-
sion and protein content, seven from the intervention group
(four male, three female) and six subjects from the control
group (six male). Subjects had no health problems and did not
use any medication which could interfere with substrate me-
tabolism. Before and after 1 year of a lifestyle-intervention
program, glucose tolerance, body composition and maximal
aerobic capacity was measured and muscle biopsies were tak-
en. Due to inadequate biopsy material we could not measure
mRNA and protein concentration in one subject from the con-
trol group. The Medical Ethics Review Committee of Maas-
tricht University approved the study protocol, and all subjects
gave their written informed consent before the start of the
study.
Lifestyle-intervention. The intervention program involved
changes in diet and physical activity. Dietary recommendations
were based on the Dutch guidelines for a healthy diet (±55 en-
ergy % carbohydrates; <30–35 energy % fat intake, with <10
energy % intake of saturated fatty acids; a cholesterol intake of
less than 33 mg per megajoule (MJ); protein intake of 10–15
energy% and an intake of dietary fibre of at least 3 g per MJ).
The goal for body weight was a BMI of less than 25 kg/m2, but
for practical reasons a body weight loss of 5 to 10 kg was
aimed at depending on the degree of obesity. Dietary advice
was given by a skilled dietician on an individual basis every 3
months. Subjects were stimulated to increase their physical ac-
tivity to at least 30 min of moderate physical activity per day
for at least 5 days a week. Individual advice was given on how
to increase their daily physical activity (walking, cycling,
swimming) and goals were set. Furthermore, subjects were 
encouraged to participate in a supervised exercise program,
consisting of components of aerobic exercise training and
components of resistance training. Participation in both, the di-
etary visits and the exercise sessions was recorded.
Subjects in the control group were informed about the ben-
eficial effects of a healthy diet, weight loss and increased phys-
ical activity, whereas no individual advice or programs were
provided. No additional appointments were scheduled.
Measurements. A standard 75-g OGTT, with blood-sampling at
t=0, t=30, t=60 and t=120 min, was done to measure glucose
tolerance and insulin concentrations. Body weight was deter-
mined on an electronic scale; body composition was deter-
mined by hydrostatic weighing with simultaneous lung volume
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measurement (Volugraph 2000, Mijnhardt, Bunnik, the Nether-
lands), and calculated according to [23]. We measured the
waist circumference of the subjects, while they were standing,
to the nearest 1 cm half way between the spina iliaca and the
last rib.
The subjects underwent an incremental exhaustive exercise
test on an electronically braked bicycle ergometer to determine
maximal aerobic capacity (VO2 max). The test started at a work-
load of 0.75 W per kg fat free mass (FFM) for 3 min, followed
by 3 min at 1.5 W per kg FFM. Thereafter, the workload was
increased every 3 min by 0.5 W per kg FFM until the subjects
became exhausted (RQ above 1.1 and no further increase in
oxygen uptake).
Needle muscle biopsies were taken before and after 1 year,
percutaneously from the vastus lateralis muscle after an over-
night fast, using the Bergstrom method with suction [24]. Bi-
opsies were immediately frozen in liquid nitrogen and stored at
−80°C until analysis.
Biochemical methods. Blood samples were collected in sodium
fluoride (glucose) or heparin (insulin) containing tubes on ice
and were immediately centrifuged at 4°C; plasma was stored at
−80°C until analysis. Plasma glucose concentration was mea-
sured with a standard enzymatic technique automated on the
Cobas Fara centrifugal analyser (Glucose HK 125, ABX diag-
nostics, Montpellier, France). Plasma insulin concentration
was measured with an ELISA assay (Mercodia, Uppsala, 
Sweden), which shows no cross-reactivity with pro-insulin.
Quantification of mRNA levels. For determination of the ex-
pression of carnitine palmitoyl transferase-2 (CPT-2), carnitine
palmitoyl transferase-1 muscle form (CPT-1m), acetyl Co-en-
zyme A carboxylase-2 (ACC-2), lipoprotein lipase (LPL), per-
oxisome proliferator-activated receptor-α (PPARα), uncou-
pling protein 2 (UCP-2), uncoupling protein 3 (UCP-3), total
RNA was isolated using the acid phenol method of Chomozyn-
ski and Sacchi [25] with an additional DNAse digestion step
with concomitant acid phenol extraction and ethanol precipita-
tion. The level of specific mRNA was determined using either
RT-competitive PCR assays (CPT2 and ACC2) or real-time
RT-PCR assays (CPT1muscle, LPL, PPARα, UCP2 and total
UCP3). For both competitive and real-time PCR, the first
strand cDNA was synthesised with the specific reverse primers
and from 0.1 µg of total RNA in experimental conditions that
warranted optimal efficiency of the reaction [26]. During the
competitive PCR, Cy-5 5′-end labelled sense primers were
used to generate fluorescent PCR products that were analysed
with an automated laser fluorescence DNA sequencer (ALFex-
press, Pharmacia, Upsala, Sweden) in 4% denaturing polyacry-
lamide gels. The initial concentration of target mRNA was de-
termined at the competition equivalence point as described
previously [26]. The real-time PCR was done by using a Light-
Cycler (Roche Diagnostics, Meylan, France) with the FastStart
DNA Master SYBR Green kit (Roche Diagnostics). After am-
plification, a melting curve analysis was done to verify the
specificity of the reaction. For quantification, a standard curve
was systematically generated with six different amounts (150
to 30 000 molecules/tube) of purified target cDNA cloned in
the pGEM plasmid (Promega). The LightCycler software
(Roche Diagnostics) was used for the analysis. The list of the
primers used for the different RT-PCR assays is available in
Table 1.
Protein expression. To determine the protein content, muscle
biopsies were homogenised in ice-cold tris-EDTA buffer at
pH 7.4. Homogenates were subsequently sonicated for 15 s,
four times. Membrane protein fatty acid translocase/CD36
(FAT/CD36) was measured by an sandwich-type ELISA [27].
To determine the cytosolic proteins, the homogenates were
centrifuged at 10 000 g for 2 min to remove cell debris (of
membranes). Tissue content of muscle-type cytosolic fatty acid
binding protein (FABPc) in skeletal muscle was measured by
means of an ELISA (Hycult Biotechnology, Uden, Nether-
lands), using recombinant human FABPc as standard [28]. 
Citrate synthase (CS) was determined according to the method
of Sherperd and Garland [29], whereas 3-hydroxyacyl-coA de-
hydrogenase (HAD) was assayed according to Bergmeyer [30].
Statistical analysis. Data are presented as means ± SEM. Dif-
ferences between groups were analysed with a two-tailed Stu-
dent’s t test for unpaired data. Pearson correlation coefficients
were calculated to assess the relation between changes in body
weight, waist circumference, VO2max and 2-h glucose on one
side and changes in expression of genes and proteins on the
other side. Statistical significance was set at a p value of less
than 0.05.
Results
Subject characteristics. All 13 subjects participating
in this study were participants from an ongoing inter-
vention trial, studying the effect of lifestyle changes
on glucose tolerance [22]; seven from the intervention
group (four men, three women) and six from the con-
trol group (six men). Baseline characteristics are de-
picted in Table 2. There were no statistically signifi-
cant differences in baseline characteristics between
groups. All seven subjects in the intervention group
were compliant to the intervention program, they at-
tended all the scheduled dietary visits and participated
at least 1 h a week in the supervised exercise sessions
throughout the year.
Table 1. List of primers used for the different RT-PCR assays
Names Forward primers Reverse primers
PPARα 5′-GCT-ATC-ATT-ACG-GAG-TCC-ACG-3′ 5′-AGC-TGC-GGT-CGC-ACT-TGT-CA-3′
UCP2 5′-GAC-CTA-TGA-CCT-CAT-CAA-GG-3′ 5′-ATA-GGT-GAC-GAA-CAT-CAC-CAC-G-3′
UCP3 5′-ATG-GAC-GCC-TAC-AGA-ACC-AT-3′ 5′-CTG-GGC-CAC-CAT-CTT-TAT-CA-3′
m-CPT1 5′-TAC-AAC-AGG-TGG-TTT-GAC-A-3′ 5′-CAG-AGG-TGC-CCA-ATG-ATG-3′
CPT2 5′-TTA-AAG-ACA-GCA-CTC-AGA-CC-3′ 5′-GTT-TTC-ATG-GTG-GCA-TCA-AAC-3′
ACC2 5′-GG-TGG-AGA-TGA-ACC-GAC-TTC-3′ 5′-ACT-CTC-CTC-CTT-CCT-CGA-TG-3′
LPL 5′-GGT-CGA-AGC-ATT-GGA-ATC-CAG-3′ 5′-TAG-GGC-ATC-TGA-GAA-CGA-GTC-3′
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The intervention group included male and female
subjects, while the control group included only male
subjects. Analysing the results in male subjects only,
however, resulted in comparable differences in gene
expression and protein content between control and
intervention group. Because of the small numbers in
both groups we included the results obtained in the 
female subjects in our final analysis.
Changes after 1 year are depicted in Table 3. Body
weight and waist circumference had decreased in the
intervention group and in the control group. The
change in waist circumference after 1 year was signif-
icantly different between groups (−3.5±1.0 cm vs
+0.3±1.1 cm for intervention and control respectively:
p=0.04). After 1 year, 2-h plasma glucose and fasting
insulin tended to decrease in the intervention group,
compared to a slight increase in the control group
(NS). Additionally, 2-h insulin decreased in the inter-
vention group and increased in the control group 
(−15.8±5.3 mU/L vs +41.8±22.1 mU/L for interven-
tion and control respectively; p=0.03).
Gene expression. Relative changes after 1 year in
genes involved in lipid metabolism in skeletal muscle,
are shown in Fig. 1. CPT-2 was upregulated in the in-
tervention group, but this increase was not different
from the increase observed in the control group after 
1 year (p=0.33). Differences in change in gene expres-
sion between groups were observed for ACC-2 and
UCP-2. Both were down-regulated in the intervention
group and up-regulated in the control group after 
1 year (relative change: ACC2: −16.8±12.4% vs
+51.5±32.3% for intervention and control respective-
ly; p<0.05) (relative change: UCP2: −26.9±10.3% vs
+10.5±6.2% for intervention and control respectively;
p<0.05). No differences were observed in change in
expression of CPT-1 muscle, LPL, PPARα and UCP3
total between groups (Fig. 1).
Protein content. Changes in content of proteins in-
volved in fatty acid transport, β-oxidation and the
Krebs-cycle are shown in Fig. 2. HAD tended to in-
crease after 1 year of intervention in the active group,
and slightly decreased in the control group
(+3.2±1.1 U/mg·ww vs −0.9±1.9 U/mg·ww respec-
tively: p=0.07 for difference in change). No signifi-
cant differences were seen in FABPc, CS and
FAT/CD36 between groups after 1 year.
Correlation between changes in subjects characteris-
tics and mRNA and protein concentrations. Correla-
tion between changes in body-weight, waist circum-
ference, VO2 max and 2-h glucose and changes in ex-
pression of genes and proteins were calculated. A cor-
relation was observed between change in UCP2 and
waist, change in HAD and 2-h glucose and between
change in FABPc and 2-h glucose (Fig. 3). Inclusion
of ‘group’ as dummy variable yielded similar results.
A decrease in UCP2 expression was associated with a
decreased waist circumference after 1 year (R=0.71;
p<0.01). Furthermore, an increase in FABPc and HAD
protein content both tended to be correlated with a de-
Table 2. Baseline characteristics
Intervention group Control group p value
n (male/female) 7 (4/3) 6 (6/0)
Age (year) 54.4±2.2 57.2±3.6 0.52
Body weight (kg) 93.7±6.7 84.0±3.7 0.26
Waist (cm) 107.0±4.2 100.4±2.3 0.22
VO2max (ml/kg/min) 26.3±1.6 29.9±1.4 0.12
2-h glucose (mmol/l) 8.4±0.7 9.4±0.8 0.34
NEFA (µmol/l) 545±34 582±53 0.55
Data are means ± SEM
Table 3. Changes after 1 year in subjects characteristics
Intervention group Control group p value
Body weight (kg) −1.5±1.2 +0.8±0.8 0.15
Waist (cm) −3.5±1.0 +0.3±1.1 0.03
VO2max (ml/kg/min) +1.6±1.0 −0.9±1.0 0.12
2-h glucose (mmol/l) −0.6±0.8 +1.0±0.8 0.19
Fast insulin (mU/l) −1.7±2.0 +3.3±1.7 0.09
2-h insulin (mU/l) −15.8±5.3 +41.8±22.1 0.02
Fast NEFA (µmol/l) −125±46 −79±28 0.46
Triglycerides (mmol/l) −0.31±0.22 +0.40±0.21 0.03
Data are mean ± SEM
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Fig. 1. Relative (%) and absolute changes (atmol/µgRNA) in
expression of several genes involved in lipid metabolism in
skeletal muscle of glucose-intolerant subjects before and after
1 year of a lifestyle intervention in the intervention (■ INT)
and control group (■ CON). Data are means ± SEM *p<0.05
between groups
Fig. 2. Changes in protein content involved in lipid metabo-
lism in skeletal muscle of glucose intolerant subjects before
and after 1 year of a lifestyle intervention in the intervention
(■ INT) and control group (■ CON). Data are means ± SEM
crease in postload glucose concentration (R=−0.57
and R=−0.56 respectively; p=0.06). Other changes in
subject characteristics were not correlated to any
changes in gene and protein expression.
Discussion
Skeletal muscle of pre-diabetic patients is character-
ised by a diminished capacity to handle fatty acids [2,
3, 4]. A diminished muscle content of several en-
zymes involved in fatty acid transport and oxidation
has been suggested to underlie these defects [3, 10].
Body weight reduction per se did not correct the meta-
bolic derangements in skeletal muscle in Type 2 dia-
betic and obese non-diabetic subjects [10, 14]. The ef-
fect on the expression of genes and proteins involved
in lipid metabolism was examined in skeletal muscle
biopsies of subjects with IGT, before and after 1 year
of a combined diet and exercise intervention program,
knowing to improve glucose tolerance and decrease
the degree of insulin resistance [22].
Expression of several genes involved in (skeletal
muscle) lipid metabolism was altered after 1 year of
intervention. ACC-2 mRNA and UCP-2 mRNA had
decreased in the intervention group but increased in
the control group, while HAD protein content tended
to increase in the intervention group compared to the
control group. Therefore, a combined diet and exer-
cise intervention program that leads to an improved
metabolic profile, can induce alterations in expression
of selected genes and proteins involved in lipid metab-
olism in muscle of glucose intolerant subjects, gener-
ally reflecting a better capacity to handle fatty acids.
Our lifestyle-intervention program resulted in sev-
eral marked changes in subjects characteristics after 
1 year. Despite the small number of subjects, differ-
ences were observed in changes in waist circumfer-
ence and in 2-h insulin concentrations already. Both
variables decreased in the intervention group and
(slightly) increased in the control group. Changes in
body weight, glucose tolerance, and insulin concentra-
tions in this study mimicked the results seen after 
1 year in the larger intervention trial, but were less
pronounced (large trial: intervention group (n=47):
body weight −2.7±0.5 kg, 2-h glucose −0.8±
0.3 mmol/l, fasting insulin −2.5±0.9 mU/l; control
group (n=55) body weight −0.2±0.5 kg, 2-h glucose
+0.2±0.3 mmol/l, fasting insulin +0.4±0.6 mU/l;
p<0.05 for difference in change; see [22]). These re-
sults confirm the known beneficial effects of changing
dietary habits and improving physical activity on glu-
cose tolerance and subsequent progression to Type 2
diabetes mellitus [20, 21].
Skeletal muscle of subjects with Type 2 diabetes or
the pre-diabetic condition of IGT is characterised by a
reduced capacity to oxidise (plasma) fatty acids [2, 3,
4]. This impaired fatty acid oxidation can be an im-
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Fig. 3 A–C Simple correlation between change in waist and
change in UCP2 expression (A) (r=0.71, p<0.01); change in 2-
h glucose and change in HAD protein (B) (r=−0.56, p=0.06);
change in 2-h glucose and change in FABPc protein content
(C) (r=−0.57, p=0.06)
portant mechanism underlying the development of the
insulin-resistant state [1, 9]. Reduced activities of sev-
eral key enzymes involved in fatty acid oxidation (CS,
HAD and CPT) was observed in muscle biopsies of
insulin-resistant obese subjects, and it was concluded
that the insulin-resistant muscle is organised toward
fat esterification rather than oxidation [10]. Weight-
loss, induced by a dietary intervention, did not im-
prove this situation [10]. We combined a dietary inter-
vention with an exercise protocol, resulting in several
(small) changes in the lipid metabolic profile of skele-
tal muscle of subjects with IGT compared to the con-
trol subjects with IGT. Acetyl CoA carboxylase-2
(ACC-2) slightly decreased in the intervention group
and increased in the control group (p<0.05 for differ-
ence in change). Our data match the observation that a
3-month low-intensity endurance training program de-
creased ACC-2 mRNA expression and improved fat
oxidation in healthy non-obese men [18]. ACC-2
plays an important role in the control of fatty acid oxi-
dation; it catalyses the formation of malonyl-CoA, an
intermediate that inhibits the activity of CPT-1. CPT-1
is responsible for the transport of fatty acyl-CoA into
mitochondria. Although changes in CPT-1 mRNA lev-
els were not different between groups in our study, we
can not rule out a difference in protein concentration
or activity of CPT-1. It is tempting to speculate that
the observed differences in ACC-2 expression under-
lie (via malonyl-CoA and CPT-1) the corresponding
changes in insulin resistance and glucose tolerance.
The combination of a decreased ACC-2 expression
and an increased HAD protein content (p=0.07) after
1 year suggests an improved capacity to oxidise fatty
acids in the intervention group. This matches our ob-
servation, in a comparable group of subjects, that total
fat oxidation and plasma NEFA oxidation during exer-
cise were slightly improved in the intervention group
and decreased in the control group after 1 year of this
lifestyle-intervention programme [31]. Furthermore,
we also found an association between increased HAD
protein content and improved glucose tolerance (i.e.
decreased 2-h glucose). The inclusion of exercise in
the protocol is most probably responsible for the
changes observed in our study, as weight loss per se
has been reported not to change the expression of sev-
eral important genes involved in skeletal muscle lipid
metabolism.[10]. Moreover, exercise training is a
powerful stimulator of lipid oxidation by increasing
the expression of genes which encode for key en-
zymes in lipid metabolism [16].
Another interesting observation is the difference
found in UCP-2 expression between groups after 
1 year: a decrease in the intervention group and an in-
crease in the control group. The decrease in UCP-2
mRNA expression after 1 year was associated with a
reduced abdominal adiposity, i.e. reduced waist cir-
cumference. These results are in agreement with earli-
er observations that UCP2mRNA expression is 
increased in skeletal muscle of obese [12] and Type 2
diabetic subjects [32]. Moreover it has been shown
that UCP2 mRNA expression is correlated with obesi-
ty [12], and decreases after (diet-induced) weight loss
[13]. Although the physiological function of UCP2 is
still not known, a role in reactive oxygen species
(ROS) production, and lipid metabolism in skeletal
muscle has been suggested [33]. Of interest, [12] an
increased UCP-2 content in obese muscle was in par-
allel with a reduced lipid utilisation. In our study
UCP-2 mRNA expression decreased after a combined
diet and exercise intervention program, in combina-
tion with an improvement in genes and proteins in-
volved in lipid utilisation (i.e. ACC-2 mRNA, HAD
and to a lesser extend CPT-1 mRNA), suggesting a
role for UCP-2 in lipid metabolism. However, it has
also been shown that UCP2 is up-regulated by fatty
acids [34]. In addition, lower NEFA concentrations in
the intervention group were responsible for the de-
creased UCP2 expression. Further studies are needed
to clarify the exact role of UCP2.
Apart from changes in the capacity to oxidise fat,
an impaired capacity to transport fatty acids has been
suggested to play a role in the impaired capacity to
utilise fat in skeletal muscle of insulin-resistant sub-
jects [3]. Although FAT/CD36 and FABPc were in-
creased in the intervention group, the changes after 
1 year were not statistically different from the control
group. However, the change in FABPc protein content
was correlated to improved glucose tolerance (i.e. de-
creased 2-h glucose), suggesting that fatty-acid trans-
port is related to an improvement in glucose tolerance.
In summary, earlier studies have shown that skele-
tal muscle of pre-diabetic patients is characterised by
a diminished capacity to utilise fatty acids [2, 3, 4].
Body weight reduction per se did not correct these
metabolic derangement’s [10, 14]. In this study, a one-
year combined diet and physical activity intervention
program improved the metabolic profile of glucose-
intolerant subjects compared to the control subjects.
This improvement was paralleled by a decreased 
expression of ACC-2 mRNA and UCP-2 mRNA and
an increased HAD protein content. These changes in-
dicate a better capacity to utilise fatty acids in skeletal
muscle. This improved handling of lipids by muscle
could be one of the mechanisms underlying the bene-
ficial effects of lifestyle-changes on glucose tolerance.
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